As of 2025-05-25, the Intrinsic Value of Aptose Biosciences Inc (APS.TO) is -20.20 CAD. This APS.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.45 CAD, the upside of Aptose Biosciences Inc is -924.48%.
Based on its market price of 2.45 CAD and our intrinsic valuation, Aptose Biosciences Inc (APS.TO) is overvalued by 924.48%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -20.20 - -20.20 | -20.20 | -924.48% |
| DDM - Stable | (279.43) - (986.97) | (633.20) | -25945.0% |
| DDM - Multi | (240.44) - (727.42) | (369.18) | -15168.5% |
| Market Cap (mil) | 2.77 |
| Beta | -0.49 |
| Outstanding shares (mil) | 1.13 |
| Enterprise Value (mil) | -7.49 |
| Market risk premium | 5.10% |
| Cost of Equity | 13.73% |
| Cost of Debt | 5.00% |
| WACC | 8.71% |